IRNF App vs Bunkerhill ECG-EF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Apple
VS
by Bunkerhill Health

AI Verdict

Tool A is a consumer-facing mobile application designed for irregular heart rhythm detection, specifically Atrial Fibrillation, using data from an Apple Watch. In contrast, Tool B is a clinical AI algorithm that analyzes routine 12-lead ECGs to detect reduced left ventricular ejection fraction, aiding in the early identification of heart failure risk within clinical workflows. While both are FDA-cleared cardiology AI tools, their distinct data sources, target users, and specific clinical applications mean they address different aspects of cardiac health and integrate into different care pathways.

Choose IRNF App if…

Choose the IRNF App if you are an individual seeking a convenient, over-the-counter solution for continuous monitoring of irregular heart rhythms suggestive of Atrial Fibrillation. This tool is ideal for proactive personal health management, leveraging your existing Apple Watch and iPhone to provide notifications and integrate data with Apple Health.

View IRNF App →

Choose Bunkerhill ECG-EF if…

Choose Bunkerhill ECG-EF if you are a healthcare provider or system looking to enhance early identification of heart failure risk within a clinical setting. This AI algorithm seamlessly integrates with EHRs to analyze routine 12-lead ECGs, offering a rapid and non-invasive diagnostic aid for detecting reduced left ventricular ejection fraction.

View Bunkerhill ECG-EF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature IRNF App Bunkerhill ECG-EF
Pricing Unknown Contact sales for pricing details.
Deployment Unknown Cloud-native platform (Carebricks) that integrates with existing health system infrastructure like EHRs.
FDA Status Unknown Yes AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

IRNF App

The IRNF App is designed for over-the-counter consumer use on familiar Apple devices, featuring clear onboarding and educational materials. This makes it highly accessible and intuitive for a broad general audience. In contrast, Bunkerhill ECG-EF focuses on seamless integration into complex clinical EHR systems, serving a specialized user group and workflow.

Clinical Value

Bunkerhill ECG-EF

While both offer significant clinical value, Bunkerhill ECG-EF directly aids clinicians in the early identification of a severe, often undiagnosed condition (reduced LVEF leading to heart failure) from a common clinical test. This can lead to more direct and impactful clinical interventions. The IRNF App provides valuable awareness for individuals, prompting them to seek medical attention for potential AFib.

Pricing & Value

IRNF App

The IRNF App is provided free of charge as a feature of compatible Apple Watch and iPhone models, offering immense value to existing users without any additional cost. Bunkerhill ECG-EF requires contacting the company for pricing, indicating a commercial, enterprise-level model for healthcare institutions.

Enterprise Readiness

Bunkerhill ECG-EF

Bunkerhill ECG-EF is explicitly designed for enterprise healthcare environments, offering HIPAA compliance, a Business Associate Agreement (BAA), and seamless integration with EHRs and clinical archives to support automated clinical workflows. The IRNF App is a consumer-facing feature and lacks these enterprise-specific attributes and compliance.

Innovation

Bunkerhill ECG-EF

While both leverage AI, Bunkerhill ECG-EF, as part of the Carebricks platform, utilizes 'Generative AI for clinical reasoning and action' to not only detect reduced LVEF from standard ECGs but also to automate subsequent clinical workflows like notifications, referrals, and prior authorizations. This represents a more advanced and integrated application of AI in healthcare operations. The IRNF App's innovation lies in democratizing FDA-cleared AFib detection on a consumer wearable.

Support & Docs

Tie

Both tools offer documentation relevant to their target users. The IRNF App provides user-friendly onboarding and educational materials for consumers, backed by Apple's extensive public support resources. Bunkerhill ECG-EF, as an enterprise solution, is expected to have professional support and implementation documentation for healthcare systems, though specific details are not as readily available in the provided facts or initial search results.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature IRNF App Bunkerhill ECG-EF
Name IRNF App Bunkerhill ECG-EF
Company Apple BunkerHill Health
Description The Apple Irregular Rhythm Notification Feature (IRNF) is an FDA-cleared software-only mobile medical application for Apple Watch and iPhone that detects irregular heart rhythms suggestive of Atrial Fibrillation (AFib) and notifies users. Bunkerhill ECG-EF is an FDA-cleared artificial intelligence algorithm by BunkerHill Health that detects reduced left ventricular ejection fraction (LVEF u2264 40%) from routine 12-lead electrocardiograms (ECGs), aiding in the early identification of patients at risk for heart failure.
Key Detection/Analysis Irregular heart rhythm detection, Atrial Fibrillation (AFib) notification Reduced Left Ventricular Ejection Fraction (LVEF u2264 40%) from routine 12-lead ECGs
Categories Cardiology AI, Wearables & Remote Monitoring (RPM) Cardiology AI

Videos

Demos, reviews, and walkthroughs featuring IRNF App and Bunkerhill ECG-EF.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Tool A, the IRNF App, provides patient-initiated notifications of irregular rhythms suggestive of AFib, with data stored in the Apple Health app, requiring patients to proactively share this information with their physician. Tool B, Bunkerhill ECG-EF, automatically analyzes routine 12-lead ECGs within existing Electronic Health Records (EHRs) or ECG management systems, providing insights directly within the clinical workflow to aid in early identification of patients at risk for heart failure.
Tool A integrates with the Apple Health app, allowing users to manage and potentially share their health data, but it does not offer direct, automated integration into a physician's EHR. Tool B is designed for seamless integration with EHRs and clinical archives, enabling automated analysis of ECG data directly within the patient's electronic medical record and supporting automated clinical workflows.
Tool A focuses on detecting irregular heart rhythms suggestive of Atrial Fibrillation (AFib) using pulse rate data from an Apple Watch's photoplethysmography (PPG) sensor. Tool B utilizes an AI algorithm to detect reduced Left Ventricular Ejection Fraction (LVEF u2264 40%) from routine 12-lead ECGs, aiding in the early identification of patients at risk for heart failure.
For Tool A, the learning curve for physicians primarily involves understanding how to interpret patient-shared data from a consumer device, with value realized through patient empowerment and potential early detection of AFib. For Tool B, the learning curve would involve familiarization with the AI's output within existing EHR or ECG management systems, with value realized through automated insights on routine ECGs for early heart failure risk identification.
Tool A provides a history of AFib notifications within the user's Apple Health app, which can be viewed by the user and potentially shared with a physician. Tool B, as an integrated AI algorithm within clinical systems, supports automated clinical workflows, which typically include audit trails for the analysis performed on 12-lead ECG data.
Implementing Tool A across multiple sites primarily involves patient education and awareness, as it is a consumer-facing application that users activate individually. For Tool B, a multi-site rollout would involve integrating the AI algorithm with the EHR and ECG management systems at each facility, requiring coordinated IT deployment and configuration.

Backers

Who funded each tool's parent company.

IRNF App

AI Tool Finder
AI-powered search. Results may not be comprehensive.